Immunalysis Benzoylecgonine Urine Enzyme Immunoassay, Immunalysis Benzoylecgonine Urine Calibrators, Immunalysis Benzoylecgonine Urine Control Set
Enzyme Immunoassay, Cocaine And Cocaine Metabolites. 510(k) K150925, from Immunalysis Corporation (Pomona, CA). Product code DIO, class 2.
As of Nov 18, 2026, K150925 is an FDA 510(k) held by Immunalysis Corporation, substantially equivalent on Jun 29, 2015 after 84 days, with no recalls tied to it in FDA's recall database.
- Review time: 84 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFImmunalysis Benzoylecgonine Urine Enzyme Immunoassay The Immunalysis Benzoylecgonine Urine Enzyme Immunoassay is a homogeneous enzyme immunoassay with a dual cutoff of 150ng/mL and 300ng/mL. The assay is intended for use in laboratories for the qualitative and semi-quantitative analysis of Benzoylecgonine in human urine with automated clinical chemistry analyzers.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Randox Cocaine MetaboliteK113751 · Randox Laboratories, Ltd. · May 8, 2012
Cited as a predicate
1 later 510(k) summary names this device as a predicate- iSy Implant SystemK151599 · Altatec GmbH · Oct 2, 2015
Other DIO clearances
The newest 510(k)s for the same product code; see every DIO device- Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test SystemK213211 · Carolina Liquid Chemistries Corp. · Jan 27, 2022
- DRI Cocaine Metabolite AssayK211973 · Microgenics Corporation · Sep 24, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 6, 2015
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files